JP2021524273A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021524273A5 JP2021524273A5 JP2021500619A JP2021500619A JP2021524273A5 JP 2021524273 A5 JP2021524273 A5 JP 2021524273A5 JP 2021500619 A JP2021500619 A JP 2021500619A JP 2021500619 A JP2021500619 A JP 2021500619A JP 2021524273 A5 JP2021524273 A5 JP 2021524273A5
- Authority
- JP
- Japan
- Prior art keywords
- norovirus
- protein
- gii
- amino acid
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001263478 Norovirus Species 0.000 claims 52
- 150000001413 amino acids Chemical group 0.000 claims 32
- 235000001014 amino acid Nutrition 0.000 claims 28
- 238000006467 substitution reaction Methods 0.000 claims 24
- 229940024606 amino acid Drugs 0.000 claims 14
- 238000000034 method Methods 0.000 claims 9
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 102000039446 nucleic acids Human genes 0.000 claims 5
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 5
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Chemical group OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical group CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Chemical group CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 3
- 229960000310 isoleucine Drugs 0.000 claims 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Chemical group CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 3
- 239000002245 particle Substances 0.000 claims 3
- 239000004474 valine Substances 0.000 claims 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical group CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical group CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 2
- 235000009582 asparagine Nutrition 0.000 claims 2
- 229960001230 asparagine Drugs 0.000 claims 2
- 230000028993 immune response Effects 0.000 claims 2
- 230000001965 increasing effect Effects 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 229930182817 methionine Chemical group 0.000 claims 2
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 2
- 208000006339 Caliciviridae Infections Diseases 0.000 claims 1
- 108020004705 Codon Proteins 0.000 claims 1
- 108700010070 Codon Usage Proteins 0.000 claims 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical group SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical group C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical group OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical group OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical group C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical group CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 1
- 241000532184 Norovirus GII Species 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Chemical group CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 1
- 239000004473 Threonine Chemical group 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Chemical group OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Chemical group SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 claims 1
- 238000003306 harvesting Methods 0.000 claims 1
- 230000036039 immunity Effects 0.000 claims 1
- 125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000419 plant extract Substances 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 235000004400 serine Nutrition 0.000 claims 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims 1
- 235000008521 threonine Nutrition 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862697770P | 2018-07-13 | 2018-07-13 | |
| US62/697,770 | 2018-07-13 | ||
| PCT/CA2018/051529 WO2020010428A1 (en) | 2018-07-13 | 2018-11-30 | Modified norovirus vp1 proteins and vlps comprising modified norovirus vp1 proteins |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021524273A JP2021524273A (ja) | 2021-09-13 |
| JP2021524273A5 true JP2021524273A5 (https=) | 2022-01-11 |
| JP7429684B2 JP7429684B2 (ja) | 2024-02-08 |
| JP7429684B6 JP7429684B6 (ja) | 2024-03-15 |
Family
ID=69143247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500619A Active JP7429684B6 (ja) | 2018-07-13 | 2018-11-30 | 改変ノロウイルスｖｐ１タンパク質および改変ノロウイルスｖｐ１タンパク質を含むｖｌｐ |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11759512B2 (https=) |
| EP (1) | EP3821014A4 (https=) |
| JP (1) | JP7429684B6 (https=) |
| CA (1) | CA3106471A1 (https=) |
| WO (1) | WO2020010428A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020098706A1 (en) * | 2018-11-13 | 2020-05-22 | Telefonaktiebolaget Lm Ericsson (Publ) | Method and apparatus for binding information management |
| WO2025077799A1 (en) * | 2023-10-12 | 2025-04-17 | Chengdu Kanghua Biological Products Co., Ltd. | Method of preparing norovirus vaccine without adjuvant |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005032457A2 (en) | 2003-07-21 | 2005-04-14 | Boyce Thompson Institute For Plant Research, Inc. | Vectors and methods for immunization against norwalk virus using transgenic plants |
| EP2066354B1 (en) | 2006-09-29 | 2013-04-17 | Ligocyte Pharmaceuticals, Inc. | Norovirus vaccine formulations |
| NO2324113T3 (https=) | 2008-08-08 | 2018-07-28 | ||
| KR101773431B1 (ko) * | 2009-09-22 | 2017-09-12 | 메디카고 인코포레이티드 | 식물-유래 ｖｌｐ의 제조방법 |
| AU2011276328C1 (en) | 2010-07-06 | 2016-01-21 | Novartis Ag | Norovirus derived immunogenic compositions and methods |
| EP2970395A4 (en) * | 2013-03-15 | 2017-03-29 | The University of North Carolina At Chapel Hill | Methods and compositions for norovirus blockade epitopes |
| US9975923B2 (en) * | 2013-03-15 | 2018-05-22 | The University Of North Carolina At Chapel Hill | Methods and compositions for norovirus blockade epitopes |
| EP4631970A3 (en) * | 2016-05-04 | 2026-01-07 | CureVac SE | Nucleic acid molecules and uses thereof |
| CA3056812C (en) * | 2017-03-23 | 2022-11-29 | Medicago Inc. | Norovirus fusion proteins and vlps comprising norovirus fusion proteins |
-
2018
- 2018-11-30 CA CA3106471A patent/CA3106471A1/en active Pending
- 2018-11-30 WO PCT/CA2018/051529 patent/WO2020010428A1/en not_active Ceased
- 2018-11-30 JP JP2021500619A patent/JP7429684B6/ja active Active
- 2018-11-30 EP EP18925849.4A patent/EP3821014A4/en active Pending
- 2018-11-30 US US17/259,789 patent/US11759512B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021503962A5 (https=) | ||
| RU2020116307A (ru) | Модифицированные белки vp1 норовируса и vlp, содержащие модифицированные белки vp1 норовируса | |
| JP2019504030A5 (https=) | ||
| CN108456663B (zh) | 一种1型牛病毒性腹泻病毒样颗粒及其制备与应用 | |
| JP2019500320A5 (https=) | ||
| US20220143175A1 (en) | Norovirus vaccines | |
| RU2014116371A (ru) | Повышение выхода вирусоподобных частиц в растениях | |
| JP2014519817A5 (https=) | ||
| JP2021524273A5 (https=) | ||
| WO2014095956A1 (en) | CANINE PARVOVIRUS TYPE 2c ISOLATES AND METHODS OF USE | |
| CN113061587A (zh) | 一种抗原谱拓展o型口蹄疫病毒株及其构建方法和应用 | |
| Gao et al. | Codon optimization of the rabbit hemorrhagic disease virus (RHDV) capsid gene leads to increased gene expression in Spodoptera frugiperda 9 (Sf9) cells | |
| RU2010125695A (ru) | Гены, кодирующие главный капсидный белок l1 вируса папилломы человека, и их применение | |
| RU2019113940A (ru) | Мозаичные вакцины от вируса ящура серотипа а | |
| EP4232082A1 (en) | Baculovirus expression vector | |
| WO2023020737A1 (en) | Fmdv virus-like particle with stabilizing mutation | |
| WO2022084426A1 (en) | Baculovirus expression vector | |
| KR102733183B1 (ko) | 중동호흡기증후군 코로나바이러스 및 이의 용도 | |
| CN105801704A (zh) | 一种具有抗宫颈癌细胞活性的重组疫苗构建方法及应用 | |
| CN1137896C (zh) | 新型口蹄疫疫苗及其制备方法 | |
| RU2020143519A (ru) | Мутанты гемагглютинина вируса гриппа | |
| RU2020143526A (ru) | Мутанты гемагглютинина вируса гриппа | |
| RU2020143530A (ru) | Мутанты гемагглютинина вируса гриппа | |
| EP4387665A1 (en) | Fmdv virus-like particle with double stabilizing mutation | |
| WO2023021168A1 (en) | Method of producing a foot and mouth disease virus virus-like particle |